Guaiatussin DAC Interactions
There are 647 drugs known to interact with Guaiatussin DAC (codeine / guaifenesin / pseudoephedrine), along with 22 disease interactions, and 2 alcohol/food interactions. Of the total drug interactions, 133 are major, 509 are moderate, and 5 are minor.
- View all 647 medications that may interact with Guaiatussin DAC
- View Guaiatussin DAC alcohol/food interactions (2)
- View Guaiatussin DAC disease interactions (22)
Most frequently checked interactions
View interaction reports for Guaiatussin DAC (codeine / guaifenesin / pseudoephedrine) and the medicines listed below.
- albuterol
- Ativan (lorazepam)
- Belviq (lorcaserin)
- Breo Ellipta (fluticasone / vilanterol)
- chlordiazepoxide / clidinium
- Crestor (rosuvastatin)
- ergocalciferol
- fluticasone nasal
- hydrochlorothiazide
- IBU (ibuprofen)
- Klor-Con M20 (potassium chloride)
- Levaquin (levofloxacin)
- Librax (chlordiazepoxide / clidinium)
- Lomotil (atropine / diphenoxylate)
- Lortab (acetaminophen / hydrocodone)
- losartan
- meloxicam
- Phenergan (promethazine)
- Prempro (conjugated estrogens / medroxyprogesterone)
- Protonix (pantoprazole)
- Singulair (montelukast)
- Soma (carisoprodol)
- Victoza (liraglutide)
- Zoloft (sertraline)
- zolpidem
Guaiatussin DAC alcohol/food interactions
There are 2 alcohol/food interactions with Guaiatussin DAC (codeine / guaifenesin / pseudoephedrine).
Guaiatussin DAC disease interactions
There are 22 disease interactions with Guaiatussin DAC (codeine / guaifenesin / pseudoephedrine) which include:
- impaired GI motility
- infectious diarrhea
- prematurity
- acute alcohol intoxication
- drug dependence
- hypotension
- intracranial pressure
- respiratory depression
- gastrointestinal obstruction
- cardiovascular disease
- adrenal insufficiency
- liver disease
- renal dysfunction
- seizure disorders
- urinary retention
- arrhythmias
- biliary tract disease
- GI narrowing
- PKU
- BPH
- diabetes
- glaucoma
More about Guaiatussin DAC (codeine / guaifenesin / pseudoephedrine)
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: upper respiratory combinations
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.